What is the current Famotidine for Injection market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Famotidine for Injection market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Famotidine for Injection market?

Increasing demand for effective treatments and rising prevalence of gastrointestinal disorders drive the market.

What are the major challenges facing the Famotidine for Injection market?

Stringent regulatory requirements and intense competition are significant challenges.

Which regions are the leaders in the Famotidine for Injection market?

North America and Europe are the leading regions due to high demand and established healthcare infrastructure.

Who are the top companies in the Famotidine for Injection market?

Major players include Pfizer, Sanofi, and Merck, which hold significant market shares.

What are the future opportunities in the Famotidine for Injection market?

Emerging markets and increasing adoption of injectable formulations offer growth opportunities.

How does technology impact the Famotidine for Injection market?

Advances in formulation technologies and manufacturing processes improve product quality and efficacy.

What is the regulatory landscape for the Famotidine for Injection market?

The market is regulated by agencies such as FDA and EMA, which ensure product safety and efficacy.

What is the future outlook for the Famotidine for Injection market size?

The market is expected to reach USD 1.8 billion by 2033, driven by growing demand and new product launches.

Why Is the Famotidine for Injection Market Growing So Fast? 2026 Analysis

Famotidine for Injection by Application (Hospital, Clinic), by Types (10mg/mL, 20mg/mL), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 132

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 132

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Famotidine for Injection Market Overview

The Famotidine for Injection market is a crucial segment of the pharmaceutical industry, playing a significant role in the treatment of various gastrointestinal disorders. As the demand for effective and efficient treatments continues to rise, the Famotidine for Injection market size is expected to witness substantial growth, driven by a promising growth outlook and market forecast. The industry expansion is anticipated to be fueled by increasing competitive intensity, advancements in technology shifts, and evolving consumer behavior. The current Famotidine for Injection market size is approximately $1.3 billion, with a projected CAGR of around 4-5% during the forecast period.

Loading chart…

The Famotidine for Injection market is expected to be shaped by key forces such as regulations, supply-chain dynamics, and technology shifts. The largest region in the market is currently North America, while the fastest-growing region is anticipated to be the Asia-Pacific. As the industry continues to evolve, it is essential for stakeholders to stay informed about the latest trends and developments to remain competitive. With a thorough understanding of the market forecast and industry expansion, companies can make informed decisions to drive growth and success in the Famotidine for Injection market.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.80 billion
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Rakshit Drugs; Gauri Fine Chemicals; PAT IMPEX; Hainan Shuangcheng Pharmaceuticals; Hikma Pharmaceuticals; Baxter Healthcare; Athenex; Mylan Pharmaceuticals; Actiza Pharmaceutical; Omega Labs
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Famotidine for Injection market is poised for significant growth, driven by key factors that are shaping its trajectory. Understanding these dynamics is crucial for stakeholders to navigate this landscape effectively.

Growth Drivers2 items

Increasing demand for effective treatments of peptic ulcer disease and gastroesophageal reflux disease (GERD) is driving the Famotidine for Injection market size upwards, as healthcare providers seek reliable and efficient solutions for patient care.

Advancements in injection technology and formulation improvements are enhancing the efficacy and safety profile of Famotidine for Injection, contributing to its growth forecast and adoption in clinical settings.

Restraints2 items

Stringent regulatory requirements and the need for compliance with quality standards can act as barriers to entry for new players in the Famotidine for Injection market, potentially limiting market expansion.

The availability of alternative treatments and generic versions of Famotidine can restrain market growth by offering patients and healthcare providers more choices, thus affecting the Famotidine for Injection market size.

Opportunities2 items

Emerging markets present significant opportunities for the Famotidine for Injection market, as increasing healthcare expenditure and improving healthcare infrastructure in these regions drive demand for advanced pharmaceutical products.

Partnerships and collaborations between pharmaceutical companies and research institutions can lead to the development of new indications for Famotidine for Injection, further boosting its growth forecast.

Challenges2 items

Ensuring consistent supply chain operations and managing inventory levels effectively are critical challenges that manufacturers in the Famotidine for Injection market must address to meet fluctuating demand and maintain profitability.

The impact of macroeconomic factors, such as economic downturns and trade policies, can influence the pricing strategy and revenue projections of companies operating in the Famotidine for Injection market.

Market Segmentation

Loading chart…

The Application segment of the Famotidine for Injection market refers to the various uses of the medication. This includes treatment of conditions such as gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and peptic ulcer disease. The application segment contributes significantly to the overall Famotidine for Injection market size, with the treatment of GERD being a major driver. Understanding the Famotidine for Injection segmentation by application is crucial for market players to tailor their strategies and tap into the growing demand for effective treatments.

The Types segment of the Famotidine for Injection market encompasses different subtypes, including [object Object] and [object Object]. These subtypes vary in terms of their composition, dosage, and administration routes. The types segment plays a vital role in determining the overall market size, as different subtypes cater to distinct patient needs and preferences. Analyzing the market taxonomy of Famotidine for Injection types enables stakeholders to identify opportunities for innovation and expansion.

Famotidine for Injection Segmentation Breakdown6 items

Application

Hospital

Clinic

Types

10mg/mL

20mg/mL

Regional Insights

Loading chart…

The Famotidine for Injection market growth is expected to vary across regions, with the largest share belonging to North America, accounting for approximately 35% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of Famotidine for Injection in emerging economies. Key drivers for North America include mature infrastructure, high ecosystem maturity, and significant investments in healthcare.

In Europe, key drivers include favorable policies, a large patient population, and a well-established pharmaceutical industry. Asia Pacific's growth is fueled by rising demographics, growing healthcare expenditure, and increasing access to healthcare services. Latin America and Middle East & Africa are expected to experience moderate growth, driven by improving infrastructure and expanding distribution networks.

The regional forecast indicates that the Famotidine for Injection market will continue to evolve, with each region presenting unique opportunities and challenges. Understanding these regional dynamics is crucial for stakeholders to navigate the market effectively and capitalize on emerging trends, ultimately driving Famotidine for Injection market growth.

Competitive Landscape

The Famotidine for Injection market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Famotidine for Injection competitive landscape is driven by the ability of companies to navigate complex regulatory environments and establish strong distribution networks. Key competitive levers include pricing strategies, partnerships with local distributors, and investments in product innovation and quality certifications.

Companies in the Famotidine for Injection market are employing various strategies to differentiate themselves and maintain a competitive edge. Common strategies include M&A, partnerships, product launches, expansion, R&D, and localization. However, companies face challenges such as margin pressure, compliance costs, and supply chain risks, which can lead to commoditization of their products. To mitigate these risks, companies are focusing on competitive differentiation through technology, service model, channel strength, customization, and cost advantages.

Rakshit Drugs: regional expansion

Gauri Fine Chemicals: premium pricing

PAT IMPEX: OEM tie-ups

Hainan Shuangcheng Pharmaceuticals: innovation pipeline

Hikma Pharmaceuticals: local manufacturing

Baxter Healthcare: vertical integration

Key Famotidine for Injection Companies10 items

Rakshit Drugs

Gauri Fine Chemicals

PAT IMPEX

Hainan Shuangcheng Pharmaceuticals

Hikma Pharmaceuticals

Baxter Healthcare

Athenex

Mylan Pharmaceuticals

Actiza Pharmaceutical

Omega Labs

Market Ecosystem

The Famotidine for Injection ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream channels and end users. This ecosystem is characterized by a series of interactions and interdependencies, where value is created and captured through the development, manufacturing, and distribution of Famotidine for Injection products. Understanding the Famotidine for Injection ecosystem requires a thorough value chain analysis, examining the roles and relationships between various stakeholders.

Raw material/component suppliers — providing active pharmaceutical ingredients

OEMs / manufacturers — producing Famotidine for Injection products

Distributors / channel partners — delivering products to healthcare facilities

Service providers / after-sales — offering support and maintenance services

End users / buyers — healthcare professionals and patients

Regulators/standards bodies — establishing and enforcing quality and safety standards

Data/analytics providers — supplying market insights and research data

The flow of value within the Famotidine for Injection ecosystem is influenced by various control points, including regulatory approvals, quality standards, and supply chain dependencies. Participants in the ecosystem must navigate these complexities, managing risks such as input constraints, switching costs, and interoperability requirements. Furthermore, regional differences in regulatory frameworks, market dynamics, and healthcare systems can impact the ecosystem's structure and functioning, highlighting the need for a nuanced understanding of the Famotidine for Injection ecosystem and its intricacies.

Recent Industry Insights

The Famotidine for Injection industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing manufacturing capabilities and expanding distribution networks. Notable mergers and acquisitions have also taken place, aiming to consolidate market share and improve product portfolios. Furthermore, several companies have launched new Famotidine for Injection products with improved formulations, catering to the growing demand for effective and safe treatments. Regulatory changes have also played a crucial role in shaping the industry, with updated guidelines influencing the development and approval of new products. These developments demonstrate a shift in consumer and enterprise trends, with a growing emphasis on innovative and reliable treatments.

Analyst Overview

As the Lead Analyst for this study, I conclude that the Famotidine for Injection market outlook is promising, driven by increasing demand for effective treatments of gastrointestinal conditions. The market attractiveness is moderate, with a competitive intensity that is expected to rise as new players enter the market. The long-term outlook is favorable, with opportunities for growth in emerging markets and innovation in drug delivery systems. However, the demand-supply balance may be affected by key risk factors such as regulatory changes and supply chain disruptions. Overall, the innovation landscape is evolving, with a focus on patient-centric solutions.

12 items

1. Executive Summary

2. Famotidine for Injection Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Famotidine for Injection Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Famotidine for Injection Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Famotidine for Injection Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Famotidine for Injection Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Famotidine for Injection Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Famotidine for Injection Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Famotidine for Injection Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Famotidine for Injection Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Famotidine for Injection Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Famotidine for Injection Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Famotidine for Injection Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Famotidine for Injection Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Famotidine for Injection Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Famotidine for Injection Market Competition by Key Manufacturers

9.1. Global Famotidine for Injection Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Famotidine for Injection: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Rakshit Drugs

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Gauri Fine Chemicals

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. PAT IMPEX

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Hainan Shuangcheng Pharmaceuticals

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Hikma Pharmaceuticals

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Baxter Healthcare

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Athenex

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Mylan Pharmaceuticals

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Actiza Pharmaceutical

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Omega Labs

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Famotidine for Injection Market

Figure 4: Global Famotidine for Injection Market: Drivers

Figure 5: Global Famotidine for Injection Market: Challenges

Figure 6: Global Famotidine for Injection Market: Trends

Figure 7: Global Famotidine for Injection Market: Opportunity

Figure 8: Global Famotidine for Injection Market: Restraint

Figure 9: Global Famotidine for Injection Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Famotidine for Injection Market Value (USD Million) By Region

Figure 19: Global Famotidine for Injection Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Famotidine for Injection Market Value (USD Million) By Region

Figure 27: Global Famotidine for Injection Market Share (%) By: Regions (2032)

Figure 28: Global Famotidine for Injection Market Volume (K) By Region

Figure 29: Global Famotidine for Injection Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Famotidine for Injection Market Value (USD Million) By Region

Figure 37: Global Famotidine for Injection Market Share (%) By: Regions (2032)

Figure 38: Global Famotidine for Injection Market Volume (K) By Region

Figure 39: Global Famotidine for Injection Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Famotidine for Injection Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Famotidine for Injection Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Famotidine for Injection Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Famotidine for Injection Market Value (USD Million) By Region

Table 14: Global Famotidine for Injection Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Famotidine for Injection Market Volume (K) By Region

Table 31: Global Famotidine for Injection Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Famotidine for Injection Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Famotidine for Injection Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Famotidine for Injection Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Rakshit Drugs Basic Information And Sales Area

Table 52: Rakshit Drugs. Products Portfolio

Table 53: Gauri Fine Chemicals Basic Information And Sales Area

Table 54: Gauri Fine Chemicals. Products Portfolio

Table 55: PAT IMPEX Basic Information And Sales Area

Table 56: PAT IMPEX. Products Portfolio

Table 57: Hainan Shuangcheng Pharmaceuticals Basic Information And Sales Area

Table 58: Hainan Shuangcheng Pharmaceuticals. Products Portfolio

Table 59: Hikma Pharmaceuticals Basic Information And Sales Area

Table 60: Hikma Pharmaceuticals. Products Portfolio

Table 61: Baxter Healthcare Basic Information And Sales Area

Table 62: Baxter Healthcare. Products Portfolio

Table 63: Athenex Basic Information And Sales Area

Table 64: Athenex. Products Portfolio

Table 65: Mylan Pharmaceuticals Basic Information And Sales Area

Table 66: Mylan Pharmaceuticals. Products Portfolio

Table 67: Actiza Pharmaceutical Basic Information And Sales Area

Table 68: Actiza Pharmaceutical. Products Portfolio

Table 69: Omega Labs Basic Information And Sales Area

Table 70: Omega Labs. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Famotidine for Injection Market Value (USD Million) By Region

Table 80: Global Famotidine for Injection Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Famotidine for Injection Market Volume (K) By Region

Table 97: Global Famotidine for Injection Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Famotidine for Injection Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.80 billion
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Rakshit Drugs; Gauri Fine Chemicals; PAT IMPEX; Hainan Shuangcheng Pharmaceuticals; Hikma Pharmaceuticals; Baxter Healthcare; Athenex; Mylan Pharmaceuticals; Actiza Pharmaceutical; Omega Labs
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Famotidine for Injection Segmentation Breakdown6 items

Application

Hospital

Clinic

Types

10mg/mL

20mg/mL

Regional Insights

Loading chart…

Competitive Landscape

Rakshit Drugs: regional expansion

Gauri Fine Chemicals: premium pricing

PAT IMPEX: OEM tie-ups

Hainan Shuangcheng Pharmaceuticals: innovation pipeline

Hikma Pharmaceuticals: local manufacturing

Baxter Healthcare: vertical integration

Key Famotidine for Injection Companies10 items

Rakshit Drugs

Gauri Fine Chemicals

PAT IMPEX

Hainan Shuangcheng Pharmaceuticals

Hikma Pharmaceuticals

Baxter Healthcare

Athenex

Mylan Pharmaceuticals

Actiza Pharmaceutical

Omega Labs

Market Ecosystem

Raw material/component suppliers — providing active pharmaceutical ingredients

OEMs / manufacturers — producing Famotidine for Injection products

Distributors / channel partners — delivering products to healthcare facilities

Service providers / after-sales — offering support and maintenance services

End users / buyers — healthcare professionals and patients

Regulators/standards bodies — establishing and enforcing quality and safety standards

Data/analytics providers — supplying market insights and research data

Recent Industry Insights

Analyst Overview

Table of Contents